Enanta Pharmaceuticals
ENTA
#7341
Rank
A$0.67 B
Marketcap
A$23.45
Share price
-3.08%
Change (1 day)
130.22%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: A$0.67 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of A$0.67 Billion. This makes Enanta Pharmaceuticals the world's 7341th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.67 B230.55%
2024A$0.20 B-29.59%
2023A$0.29 B-79.54%
2022A$1.42 B-32.78%
2021A$2.11 B92.39%
2020A$1.09 B-37.11%
2019A$1.74 B-10.54%
2018A$1.95 B35.93%
2017A$1.43 B62.46%
2016A$0.88 B3.87%
2015A$0.85 B-26.34%
2014A$1.15 B110.48%
2013A$0.54 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

A$0.69 Billion
by Nasdaq info icon info icon
A$0.69 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
A$603.66 B 89,077.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$740.15 B 109,240.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$175.76 B 25,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$391.68 B 57,762.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$164.96 B 24,269.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$398.54 B 58,775.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland